2017 American Transplant Congress
Intraabdominal Infections (IAI) and Bloodstream Infections in Small Intestinal and Multivisceral Transplants (IMVTX).
BackgroundIMVTX is a treatment option for patients with intestinal failure. IMVTX is often complicated by infection in the post-transplant period with the abdomen and bloodstream…2017 American Transplant Congress
Clinical Experience with Novel Cephalosporin/Beta-Lactamase Inhibitor Combinations in the Treatment of Multidrug Resistant Pseudomonas aeruginosa and Carbapenem-Resistant Enterobacteriaceae in Solid Organ Transplant Recipients.
Purpose: To review clinical outcomes in organ transplant recipients (OTRs) treated with Ceftazidime/avibactam (C/A) and ceftolozane/tazobactam (C/T) for infections caused by Multidrug resistant Pseudomonas aeruginosa…2016 American Transplant Congress
The Surgical Preconditioning in Patients with Ultra-Short Gut Using a Native Colonic Conduit for Anticipated Visceral Transplantation.
Center of Gut Rehabilitation and Transplant, Cleveland Clinic, Cleveland, OH.
Objective: The last decade witnessed the significant improvement in the morbidity and mortality of short gut syndrome (SGS) patients. However, still a challenge is the…2015 American Transplant Congress
Deep Surgical Site Infections (dSSI) After Liver Transplantation (LTx): Emergence of Multiple-Drug Resistant (MDR) Pathogens
Purpose: We described the epidemiology, microbiology and outcomes of dSSI after LTx.Methods: We performed a single center retrospective study of 332 consecutive patients undergoing LTX…2015 American Transplant Congress
Surgical Site Infections After Intestinal and Multivisceral Transplantation
Transplant Institute, MedStar Georgetown University Hospital, Washington, DC.
Aim:Intestinal transplant (ITx) recipients harbor risk factors implicated in surgical site infections (SSI): multiple prior abdominal surgeries, complex operative course, grafts with significant microbial load,…2015 American Transplant Congress
Patients With Spontaneous Bacterial Peritonitis (SBP) Experience Survival Benefit After Live Donor Liver Transplantation (LDLT)
Transplantation and Hepatobiliary Diseases, Lahey Hospital and Medical Center, Burlington, MA.
Background: SBP is a life threatening complication of end stage liver disease. Reports indicate a 40-50% one year mortality rate in patients who experience SBP…
American Transplant Congress abstracts